Chapter 23
Evolution of Evidence-Based Outcomes for Percutaneous Management
Matthew J. O'Shaughnessy,
David A. Leavitt, J. Kyle Anderson,
Matthew J. O'Shaughnessy
University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorMatthew J. O'Shaughnessy,
David A. Leavitt, J. Kyle Anderson,
Matthew J. O'Shaughnessy
University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorBook Editor(s):Manoj Monga MD, FACS,
Abhay Rane MS, FRCS(Urol),
Manoj Monga MD, FACS
Director
Stevan B. Streem Center for Endourology and Stone Disease, Glickman Urological and Kidney Institute, Cleveland Clinic Cleveland, OH, USA
Search for more papers by this authorAbhay Rane MS, FRCS(Urol)
Professor of Urology
East Surrey Hospital, Redhill, UK
Search for more papers by this authorFirst published: 25 October 2013
Summary
Percutaneous ablation has been developed over the last two decades to provide a minimally invasive treatment option for patients with renal masses. Despite increased use of this technology, data on percutaneous ablation are largely limited to observational studies with little significant comparison with other treatment options. Within these limitations, percutaneous ablation is proving to be a very viable alternative for selected patients, especially those with small renal masses and/or comorbidities that may limit more invasive treatments.
References
- Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182: 1271.
- Ljungberg B, Cowan NC, Hanbury DC, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58: 398.
- Stephenson AJ, Chetner MP, Rourke K, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 2004; 172: 58.
- Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe:the small renal mass dilemma – a meta-analysis and review. J Urol 2008; 179: 1227.
- Weight CJ, Kaouk JH, Hegarty NJ, et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 2008; 179: 1277.
- Mues AC, Landman J. Results of kidney tumor cryoablation: renal function preservation and oncologic efficacy. World J Urol 2010; 28: 565.
- Faddegon S, Cadeddu JA. Does renal mass ablation provide adequate long-term oncologic control? Urol Clin North Am 2012; 39: 181.
- Finley DS, Beck S, Box G, et al. Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 2008; 180: 492.
- Atwell TD, Callstrom MR, Farrell MA, et al. Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol 2010; 184: 1291.
- Mues AC, Okhunov Z, Haramis G, et al. Comparison of percutaneous and laparoscopic renal cryoablation for small (<3.0 cm) renal masses. J Endourol 2010; 24: 1097.
- Bandi G, Hedican S, Moon T, et al. Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses. J Endourol 2008; 22: 963.
- Ferakis N, Bouropoulos C, Granitsas T, et al. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J Endourol 2010; 24: 1909.
- Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008; 180: 499.
- Tracy CR, Raman JD, Donnally C, et al. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010; 116: 3135.
- Best SL, Park SK, Yaacoub RF, et al. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol 2012; 187: 1183.
- Olweny EO, Park SK, Tan YK, et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 2012; 61: 1156.
- Zagoria RJ, Pettus JA, Rogers M, et al. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 2011; 77: 1393.
- Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 2008; 113: 2671.
- Pirasteh A, Snyder L, Boncher N, et al. Cryoablation vs. radiofrequency ablation for small renal masses. Acad Radiol 2011; 18: 97.
- Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175: 425.
- Goyal J, Verma P, Sidana A, et al. Single-center comparative oncologic outcomes of surgical and percutaneous cryoablation for treatment of renal tumors. J Endourol 2012; 26: 1413–19.
- Aron M, Kamoi K, Remer E, et al. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol 2010; 183: 889.
- Guazzoni G, Cestari A, Buffi N, et al. Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. Urology 2010; 76: 624.
- Psutka SP, Feldman AS, McDougal WS, et al. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63: 486–92.
- Takaki H, Yamakado K, Soga N, et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Japan J Radiol 2010; 28: 460.
- Choueiri TK, Schutz FA, Hevelone ND, et al. Thermal ablation versus surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Urology 2011; 78: 93.
- Johnson DB, Solomon SB, Su LM, et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol 2004; 172: 874.
- Atwell TD, Carter RE, Schmit GD, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Intervent Radiol 2012; 23: 48.
- Tsivian M, Chen VH, Kim CY, et al. Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center. Eur Urol 2010; 58: 142.
- Rosenberg MD, Kim CY, Tsivian M, et al. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications. Am J Roentgenol 2011; 196: 935.
- Jacobsohn KM, Ahrar K, Wood CG, et al. Is radiofrequency ablation safe for solitary kidneys? Urology 2007; 69: 819.
- Johnson DB, Taylor GD, Lotan Y, et al. The effects of radio frequency ablation on renal function and blood pressure. J Urol 2003; 170: 2234.
- Hegarty NJ, Gill IS, Desai MM, et al. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 2006; 68: 7.
- Malcolm JB, Logan JE, Given RW, et al. Renal functional outcomes after cryoablation of small renal masses. J Endourol 2010; 24: 479.
- Lucas SM, Stern JM, Adibi M, et al. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179: 75.
- Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296.
- Pettus JA, Werle DM, Saunders W, et al. Percutaneous radiofrequency ablation does not affect glomerular filtration rate. J Endourol 2010; 24: 1687.
- Wehrenberg-Klee E, Clark TW, Malkowicz SB, et al. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Intervent Radiol 2012; 23: 41.
- Link RE, Permpongkosol S, Gupta A, et al. Cost analysis of open, laparoscopic, and percutaneous treatment options for nephron-sparing surgery. J Endourol 2006; 20: 782.
- Badwan K, Maxwell K, Venkatesh R, et al. Comparison of laparoscopic and percutaneous cryoablation of renal tumors: a cost analysis. J Endourol 2008; 22: 1275.
- Castle SM, Gorbatiy V, Avallone MA, et al. Cost comparison of nephron-sparing treatments for cT1a renal masses. Urol Oncol 21 Feb 2012 (epub ahead of print).
- Lotan Y, Cadeddu JA. A cost comparison of nephron-sparing surgical techniques for renal tumour. BJU Int 2005; 95: 1039.
- Kang DC, Palmer DA, Zarei M, et al. A systematic review of the quality of evidence of ablative therapy for small renal masses. J Urol 2012; 187: 44.
